Perinatal and neonatal management plan for prevention and control of 2019 novel coronavirus infection (1st Edition)
Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics
Abstract Since December 2019, the novel coronavirus (2019-nCoV) infection has been prevalent in China. Due to immaturity of immune function and the possibility of mother-fetal vertical transmission, neonates are particularly susceptible to 2019-nCoV. The perinatal-neonatal departments should cooperate closely and take integrated approaches, and the neonatal intensive care unit should prepare the emergency plan for 2019-nCoV infection as far as possible, so as to ensure the optimal management and treatment of potential victims. According to the latest 2019-nCoV national management plan and the actual situation, the Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editorial Committee of Chinese Journal of Contemporary Pediatrics puts forward recommendations for the prevention and control of 2019-nCoV infection in neonates.
Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editoral. Perinatal and neonatal management plan for prevention and control of 2019 novel coronavirus infection (1st Edition)[J]. CJCP, 2020, 22(2): 87-90.
Working Group for the Prevention and Control of Neonatal 2019-nCoV Infection in the Perinatal Period of the Editoral. Perinatal and neonatal management plan for prevention and control of 2019 novel coronavirus infection (1st Edition)[J]. CJCP, 2020, 22(2): 87-90.
Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020. Epub ahead of Print.
[3]
World Health Organization. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases[EB/ OL]. (2020-01-14). https://www.who.int/docs/default-source/ coronaviruse/20200114-interim-laboratory-guidance-version.pdf ?sfvrsn=6967c39b_4&download=true.
[4]
World Health Organization.SARS (severe acute respiratory syndrome)(2019)[EB/OL]. https://www.who.int/ith/diseases/ sars/en/.
[5]
Azhar EI, Hui DSC, Memish ZA, et al. The middle east respiratory syndrome (MERS)[J]. Infect Disease Clin North Am, 2019, 33(4): 891-905.
[6]
Li AM, Ng PC. Severe acute respiratory syndrome (SARS) in neonates and children[J]. Arch Dis Child Fetal Neonatal Ed, 2005, 90(6): F461-F465.
[7]
Gagneur A, Vallet S, Talbot PJ, et al. Outbreaks of human coronavirus in a pediatric and neonatal intensive care unit[J]. Eur J Pediatr, 2008, 167(12): 1427-1434.
[8]
Zhang N, Wang L, Deng X, et al. Recent advances in the detection of respiratory virus infection in humans[J]. J Med Virol, 2020. Epub ahead of Print.
[9]
Chen Y, Liu Q, Guo D. Coronaviruses: genome structure, replication, and pathogenesis[J]. J Med Virol, 2020. Epub ahead of Print.
[10]
Totura AL, Bavari S. Broad-spectrum coronavirus antiviral drug discovery[J]. Expert Opin Drug Discov, 2019, 14(4): 397-412.
